
GSK Regional Vaccine Distribution Hub in Abu Dhabi receives first shipments
ABU DHABI (ALETIHAD)The Department of Health – Abu Dhabi (DoH) has announced the operational launch of the region's vaccine distribution hub in Abu Dhabi, following the arrival of the facility's first shipments.Located in Abu Dhabi and developed in partnership with leading global and regional stakeholders, the hub is a strategic milestone in the emirate's vision to strengthen global health security, ensure equitable vaccine access, and build resilient supply chains across the region.Located in KEZAD and operated by Rafed, a subsidiary of PureHealth, the hub was developed in collaboration with the DoH, Abu Dhabi Investment Office (ADIO), GSK, AD Ports Group, Etihad Cargo, and KEZAD Group.It is a cornerstone of the UAE's expanding life sciences ecosystem and is designed to improve vaccine access across the region.The hub leverages Abu Dhabi's strategic location, its advanced cold-chain logistics infrastructure, and a regulatory environment that is both agile and supportive of innovation. This hub reflects Abu Dhabi's model of cross-sector collaboration, uniting government, biopharma, logistics, and innovation under one ecosystem.The activation of the hub follows a strategic agreement signed between DoH and GSK during Abu Dhabi Global Healthcare Week in 2024 to establish regional vaccine distribution capabilities in the emirate.Now realised, the facility becomes GSK's first vaccine distribution centre in the Middle East and the fourth worldwide, further solidifying Abu Dhabi's role in supporting regional health security and global supply chain resilience.The hub's activation also marks one of the first major operational milestones under HELM – Abu Dhabi's Life Science Cluster, which was officially launched in April 2025 during Abu Dhabi Global Health Week.As the emirate's flagship platform to drive life sciences investment, innovation, and global collaboration, HELM brings together government, industry, and academia to strengthen Abu Dhabi's position as a preferred global partner in precision health, pharmaceutical manufacturing, and biopharma logistics. The hub's integration under HELM demonstrates how Abu Dhabi is translating its life sciences vision into operational outcomes that drive regional impact. Her Excellency Dr Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said, 'The operational launch of Abu Dhabi's regional vaccine hub signals our readiness to serve the region with speed, precision, and reliability. More than a logistics milestone, this reflects our long-term vision to position Abu Dhabi as a trusted partner in global health where innovation and resilience translate into timely access and measurable public health impact. Through this hub, we are making vaccines more accessible to communities across borders and strengthening the UAE's leadership in preventive, future-ready healthcare.'The facility will manage a portfolio of more than 20 vaccines, including those for paediatric and adult populations, supporting lifelong immunisation strategies across multiple markets. Designed for scalability, the hub can accommodate emerging vaccine technologies and increased regional demand while maintaining the highest global quality and safety standards.Vice President and General Manager, GSK Gulf, Boyd Chongphaisal, said, 'The launch of our vaccine distribution hub in Abu Dhabi represents a shared commitment to health security, innovation, and access. Through our strategic partnership with DoH and local stakeholders, we are combining scientific excellence with operational strength to ensure the timely, efficient delivery of vaccines across the region. The integration of this hub under HELM further demonstrates GSK's pioneering stance and alignment with Abu Dhabi's vision for driving impactful outcomes in the life sciences sector on a regional and global scale. This initiative is also a testament to Abu Dhabi's position in the global value chain, strengthening its role in global health and innovation.'Rafed, the operator of the facility, has deployed advanced cold-chain and smart distribution technologies that preserve vaccine integrity and ensure end-to-end visibility throughout the logistics process. The hub is fully integrated with Etihad Cargo's PharmaLife network, which connects Abu Dhabi to more than 100 international destinations and offers time-sensitive, temperature-controlled freight services tailored for pharmaceutical products.Chief Executive Officer of Rafed, Mohammad Mustafa Saeed, said, 'As a PureHealth company, Rafed is committed to delivering healthcare excellence through world-class pharmaceutical logistics. The launch of this regional vaccine distribution hub is a tangible expression of our strategy to strengthen health systems, improve access, and build resilience across borders. By deploying advanced cold-chain and smart distribution technologies, we are enabling real-time, end-to-end visibility. We remain focused on supporting governments and health partners with confidence and reliability to achieve better health outcomes for communities from Abu Dhabi across the Middle East, Africa, and South Asia.'The facility is expected to distribute millions of doses annually, shortening delivery timelines across the region and improving the integrity of vaccine supply.Chief Cargo Officer at Etihad Airways, Stanislas Brun, said, 'Etihad Cargo's participation in this initiative reflects our continued investment in healthcare logistics. Our network and specialised PharmaLife product play a critical role in transporting temperature-sensitive vaccines reliably and efficiently across the region. We are proud to support Abu Dhabi's vision of becoming a global leader in life sciences and supply chain excellence.'The facility's activation significantly strengthens Abu Dhabi's life sciences value chain and supports its ambition to serve as a global hub for innovation-led, knowledge-based industries.
Its operational readiness will help improve vaccine access, reduce delivery lead times, and address public health needs through a more proactive and resilient healthcare model.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Filipino Times
6 days ago
- Filipino Times
DOH on alert for rise in leptospirosis cases after heavy rains
The Department of Health (DOH) is closely monitoring a possible increase in leptospirosis cases following weeks of heavy rains and widespread flooding brought by three tropical cyclones and the Southwest Monsoon or Habagat. In an advisory, the DOH said it has recorded a total of 3,037 leptospirosis cases from January 1 to July 19, 2025. Of this number, 1,114 cases were logged between June 8 and July 19, just days after PAGASA officially declared the start of the rainy season. From July 13 to 31 alone, DOH-run hospitals recorded 569 leptospirosis cases. Leptospirosis is a potentially fatal bacterial infection transmitted through water contaminated with the urine of infected animals, particularly rats. People exposed to floodwaters are at higher risk, especially if they have open wounds or broken skin. The DOH reminded the public to take the following precautions: •Wash the body thoroughly with soap after exposure to floodwaters, especially affected areas. •Monitor for symptoms such as fever, muscle pain, and vomiting. •Seek medical attention even in the absence of symptoms if exposed to floodwater. •Take prophylactic medicine against leptospirosis only upon a doctor's prescription. The Health Department urged local government units and communities to remain vigilant and strengthen public health measures to prevent further infections.


Khaleej Times
6 days ago
- Khaleej Times
Philippines braces for rise in leptospirosis cases after weeks of heavy rains, flooding
Health officials in the Philippines are warning of a possible surge in leptospirosis cases after persistent heavy rains triggered by the southwest monsoon and a series of tropical cyclones in recent weeks. According to the Department of Health reported that 569 leptospirosis cases were recorded in hospitals nationwide between July 13 and 31. Leptospirosis is an infection that can be transmitted to humans through floodwaters contaminated with the urine of infected animals, particularly rats. In a statement released on Saturday (August 2), the quoting DOH said: 'In connection with the continuous rains caused by the tropical cyclones and the southwest monsoon last week, the DOH is on alert for the expected rise in leptospirosis cases in the country." The DOH urged the public to take precautions after exposure to floodwater. 'Immediately wash your body after wading in floodwater. Monitor yourself for any symptoms. Even without symptoms, consult a doctor if you have gone into floodwater. Only take leptospirosis medicine if prescribed by your doctor." Among the recent weather conditions that contributed to flooding were Tropical Depression Crising (Tropical Storm Wipha), which exited the Philippine Area of Responsibility (PAR) on July 19, and Tropical Storm Dante (Typhoon Francisco), which left on July 24 — both without making landfall. Meanwhile, Tropical Storm Emong (Typhoon Co-May) hit land twice — first in Pangasinan on July 24 and then in Ilocos Sur on July 25 — before leaving the PAR on July 26. The combined impact of the southwest monsoon (habagat) and three tropical cyclones has resulted in the deaths of at least 37 people across the Philippines, according to citing the latest update from the National Disaster Risk Reduction and Management Council (NDRRMC) as of Thursday (July 31). Most of the deaths were reported in Metro Manila, with nine, followed by Calabarzon with eight and Western Visayas with six. Eight people remain missing, while 22 were reported injured due to the recent weather disturbances.


Al Etihad
30-07-2025
- Al Etihad
Department of Health – Abu Dhabi launches Rewarding Exceptional Quality programme, recognising excellence by healthcare providers
30 July 2025 16:39 ABU DHABI (ALETIHAD)The Department of Health – Abu Dhabi (DoH) has launched a new value-based healthcare initiative under its Rewarding Exceptional Quality programme, aimed at incentivising healthcare providers based on the quality of care they programme will initially focus on fertility services and is set to expand to other clinical areas in subsequent phases, further reinforcing Abu Dhabi's position as a world-class healthcare initiative is part of Abu Dhabi's continued commitment to elevating the standard of care across the emirate, where the department will monitor the performance of healthcare facilities based on specific models and facilities will be rewarded with additional incentives for achieving set performance goals within a specified timeframe, such as improving patient outcomes, utilising best medical practices, boosting patient safety, and enhancing the patient Excellency Dr Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi – Abu Dhabi, said, 'At the Department of Health – Abu Dhabi, we are committed to raising the bar for healthcare quality in Abu Dhabi. The launch of the Rewarding Exceptional Quality programme reflects our ambition to drive meaningful improvements in clinical performance while rewarding providers that go above and beyond in delivering safe, effective, and patient-centred care.''Fertility services were chosen as the starting point given their strategic importance to public health and the profound impact they have on families. Abu Dhabi has already made tremendous strides in advancing reproductive medicine, and this programme will help accelerate progress even further.'Abu Dhabi has become a leading destination for fertility care, driven by innovation in treatments such as egg freezing, in vitro fertilisation (IVF), and embryo 2025, the Department of Health – Abu Dhabi reported that IVF success rates in the emirate exceeded 51 percent, among the highest globally, with more than 6,180 IVF cycles performed in 2024 emirate is home to 14 advanced fertility centres and more than 2,800 healthcare professionals in obstetrics and gynaecology. This includes 700 specialists and consultants, 375 midwives, and 45 facilities dedicated to women's health.